In this study, we found that IGFBP7 contributes to resistance to EGFR-TKIs and showed that enhanced IGFBP7 expression promoted resistance to EGFR-TKI in lung cancer cells by mediating the IGF-1R pathway. This evidence concerns the gene EGFR and lung carcinoma.